Variants of the PPARD Gene and Their Clinicopathological Significance in Colorectal CancerReportar como inadecuado

Variants of the PPARD Gene and Their Clinicopathological Significance in Colorectal Cancer - Descarga este documento en PDF. Documentación en PDF para descargar gratis. Disponible también para leer online.


Peroxisome proliferator-activated receptor delta PPARD is nuclear hormone receptor involved in colorectal cancer CRC differentiation and progression. The purpose of this study was to determine prevalence and spectrum of variants in the PPARD gene in CRC, and their contribution to clinicopathological endpoints.

Methods and Findings

Direct sequencing of the PPARD gene was performed in 303 primary tumors, in blood samples from 50 patients with ≥3 affected first-degree relatives, 50 patients with 2 affected first-degree relatives, 50 sporadic patients, 360 healthy controls, and in 6 colon cancer cell lines. Mutation analysis revealed 22 different transversions, 7 of them were novel. Three of all variants were somatic c.548A>G, p.Y183C, c.425-9C>T, and c.628-16G>A. Two missense mutations p.Y183C and p.R258Q were pathogenic using in silico predictive program. Five recurrent variants were detected in-adjacent to the exons 4 c.1-87T>C, c.1-67G>A, c.130+3G>A, and c.1-101-8C>T and exon 7 c.489T>C. Variant c.489C-C detected in tumors was correlated to worse differentiation P = 0.0397.


We found 7 novel variants among 22 inherited or acquired PPARD variants. Somatic and-or missense variants detected in CRC patients are rare but indicate the clinical importance of the PPARD gene.

Autor: Ivana Ticha , Sebastian Gnosa, Annika Lindblom, Tao Liu, Xiao-Feng Sun



Documentos relacionados